This site is intended for healthcare professionals

Medthority home page banner

Sign up for our newsletter

The medical news you don’t want to miss

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information

Name

Email address

Specialty

By providing your email address, you are opting in to receive our monthly newsletter.

Opt-in: By selecting this box, I consent to receiving marketing communications and information about Medthority's resources by email.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

3D illustration of a thrombus inside a human blood vessel, with fibrin strands trapping red blood cells and causing occlusion.

Risk and anticoagulation at EHA2026

VTE models, ADAPT-BLEED, and DOAC vs warfarin

3D illustration of amyloidosis, with purple protein clusters building up along pink fibrils on a blue background.

Linvoseltamab in AL amyloidosis

Rapid, deep responses in early-phase study

3D illustration of amyloidosis, showing pink protein deposits building up along beige fibrils on a black background.

Anselamimab in AL: Phase 3 data

κ subgroup benefit observed in CARES trial

Conference venue hallway with large ASCO banners overhead reading “The Place to Belong” and “Where Science Saves Lives.”

Nivolumab: No DFS benefit in NSCLC

Phase 3 EA5142 results presented at ASCO 2026

No OS detriment with durvalumab

POTOMAC shows stable OS and QoL

Ivonescimab improves OS in NSCLC

HARMONi-6 shows OS benefit vs PD-1

Read more medical news stories here.